Development and Validation of a Reliable HPLC Method for Chlorpromazine Analysis

References

[1] Walfish, S. Analytical methods: a statistical perspective on the ICH Q2A and Q2B guidelines for validation of analytical methods. Biopharm. Int. 2006, 19(12), 1–6.

[2] Shaji, J.; et, al.Development and validation of a reverse phase HPLC method for determination of meloxicam in pharmaceutical dosage forms and human plasma. Int. J. Pharm. Sci. Rev. Res. 2012, 12(1), 152–60.

[3] Qi, M.-L.; et , al. Validateda liquid cpalatography method for assay of tizanidine in drug substance and formulated products. Analytica Chim. Acta 2003, 478(2), 171–7.

[4] Fuster, J.; et, al. HPLC-UV method development and validation for the quantification of ropinirole in new PLGA multi particulate systems: microspheres and nanoparticles. Int. J. Pharm. 2015, 491(1), 310–7.

[5] Segundo, et, al.Development and validation of HPLC method with fluorometric detection for quantification of bisnaphthalimidopropyldiaminooctane in animal tissues following administration in polymeric nanoparticles. J. Pharm. Biomed. Anal. 2016, 120, 290–6.

[6] Pethkar, S. Development and validation of UV spectrophotometric method for analysis of nortriptyline hydrochloride in bulk and tablet dosage form. World J. Pharm. Pharm. Sci. 2016, 5(7), 1452–9. 46.

[7] S.; Özaydin, T et, al. Development and validation of a reversed-phase HPLC method for the determination of lisinopril and gliclazide in pharmaceuticals. Marmara Pharm. J. 2017, 21(2), 338–44. 47.

[8] Akhlaq, M, et, al. Abdelkader, H. A simple high-performance liquid chromatographic practical approach for determination of flurbiprofen. J. Adv. Pharm. Technol. Res. 2011, 2(3), 151.

[9] International Conference on Harmonisation. 1994. Test on Validation of Analytical Procedures, US FDA Federal register.

[10] Lu, C.; et, al.Simultaneous determination of ivabradine and N-desmethyl ivabradine in human plasma and urine using an LC-MS/MS method: application to a pharmacokinetic study. Acta Pharm. Sinica B 2012, 2(2), 205–12.

[11] Vella Szijj, et, al. The combined effects of pH and acetonitrile composition on the separation of two Lincosamide antibiotics. Asian J. Pharm. Clin. Res. 2014.

[12] Moldoveanu, et, al. Parameters that characterize HPLC analysis. Essentials Mod. HPLC Separations 2013, 53–83.

[13] Moldoveanu, S.C.; et, al. Parameters that characterize HPLC analysis. Essentials Mod. HPLC Separations 2013, 53–83.

[14] Hasan, N.; et, al.Dual wavelength RP-HPLC method for simultaneous determination of two antispasmodic drugs: an application in pharmaceutical and human serum. J. Anal. Methods Chem. 2013, 20.

[15] Chandraiah, M.R.; et, al. RP-HPLC method for estimation of itopride hydrochloride from the tablets dosage form. J. Chem. Pharm. Res. 2012, 4(5), 2649–51.

[16] Suneetha, D.; et, al.RP-HPLC method for the estimation of eletriptan in pharmaceutical dosage forms. Int. J. Chem. Environ. Pharm. Res. 2010, 1(2), 95–9.

[17] Kaul, N.; et, al.Application of HPLC and HPTLC for the simultaneous determination of tizanidine and rofecoxib in the pharmaceutical dosage form. J. Pharm. Biomed. Anal. 2005, 37(1), 27–38

[18] Rajan, V.T.; et, al. A simple RP-HPLC method for quantitation of itopride HCl in the tablet dosage form. J. Young Pharm. 2010, 2(4), 410–3.

[19] Perumal, S.S.; et, al. Analytical method development and validation of simultaneous estimation of rabeprazole, pantoprazole, and itopride by reverse-phase high-performance liquid chromatography. J. Food Drug Anal. 2014, 22(4), 520–6.

[20] Naik, D.S.; et, al.Method development and validation of eletriptan hydrobromide pharmaceutical dosage form by RP-HPLC. Int. J. Eng. Res. Appl. 2013, 3(6), 1–5

[21] Shao, Y.; et, al.A stability indicating HPLC method for the determination of glucosamine in pharmaceutical formulations. J. Pharm. Biomed. Anal. 2004, 35(3), 625–31.

@article{1720030,
      author = {Makrand Hanumant Ekatpure, Iram Naaz Shaikh, Archit Desai, Ayush Kate, Uzma Khan; Gaurav Yadav},
      title = {Development and Validation of a Reliable HPLC Method for Chlorpromazine Analysis},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {10},
      number = {1},
      pages = {2736-2755},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1720030.pdf},
      abstract = {The present study aimed to develop and validate a simple, accurate, precise, robust, and cost-effective reverse-phase high-performance liquid chromatography (RP-HPLC) method for the quantitative estimation of chlorpromazine in bulk drug and tablet dosage forms in accordance with ICH guidelines. Chromatographic separation was achieved using a C18 column (250 × 4.6 mm, 5 µm) with an optimized mobile phase consisting of acetonitrile and water (40:60, v/v) adjusted to pH 3.5, at a flow rate of 1.0 mL/min and UV detection at 260 nm. The developed method exhibited excellent linearity over the concentration range of 10–60 µg/mL with a correlation coefficient (R²) of 0.9899. Validation studies demonstrated satisfactory accuracy (98.2–102.68% recovery), precision (%RSD < 2%), specificity, robustness, and system suitability. The method showed high sensitivity with low limits of detection (LOD) and quantification (LOQ), making it suitable for routine pharmaceutical quality control. Additionally, a Quality by Design (QbD)-based robustness assessment employing Central Composite Design (CCD) was performed to evaluate the influence of critical method parameters, including pH, mobile phase composition, and flow rate, on critical quality attributes. Statistical analysis using ANOVA confirmed the significance and reliability of the optimized chromatographic conditions. The developed RP-HPLC method is simple, reproducible, environmentally conscious due to reduced solvent consumption, and well suited for routine estimation of chlorpromazine in pharmaceutical formulations.},
      keywords = {Chlorpromazine, RP-HPLC, Method Development, Method Validation, Quality by Design (QbD), Central Composite Design (CCD), ICH Guidelines, Pharmaceutical Analysis, Robustness, Quality Control, Reverse Phase High-Performance Liquid Chromatography, Analytical Method Validation},
      month = {July},
      doi = {https://doi.org/10.64388/IREV10I1-1720030}
  }